Enfamil EnfaCare Nursettes Ready to Feed Infant Formula Bottles - 2 fl oz/6ct
$10.99
$14.29
Disponibilité:
En stock-
Livraison estimée:Feb 18 - Feb 25
-
Expédition et retours gratuits: On all orders
Paiement sécurisé garanti
- Free Shipping & Returns or all orders over
- Secure Payment We ensure secure payment
- Money Back Guarantee Any back within 30 days
Product Description
Enfamil NeuroPro EnfaCare is a milk-based, 22 Cal/fl oz, iron-fortified, post-discharge baby formula milk that has enriched* nutrition for immune support for infants who were born prematurely or with low birth weight transitioning to home. Enfamil NeuroPro EnfaCare is the only post-discharge formula that has a fat-protein blend of MFGM† and DHA, previously only found in breast milk. Enfamil NeuroPro EnfaCare newborn baby formula has vitamin and mineral amounts specially tailored for premature babies’ first year of life after discharge from the hospital.Product Highlights
- CONTAINS: Six pack of 2 Fl Oz newborn baby bottles of Enfamil NeuroPro EnfaCare Ready to Feed Premature Newborn Baby Formula Milk
- ON THE GO: Convenient and ready to use bottles, perfect for late night feedings or on-the-go moms. Made with NON-GMO ingredients
- SUPPORTS IMMUNE SYSTEM: Milk-based, 22 Cal/fl oz formula with enriched nutrition and a blend of nutrients to help support baby's immune system
- PROMOTES CATCH-UP GROWTH: Clinically proven to promote catch-up growth similar to full-term breastfed infants
- EXPERT RECOMMENDED OMEGA-3 DHA: A amount for brain building nutrition inspired by breast milk from the formula brand that's
- BRAIN-BUILDING NUTRITION: Inspired by breast milk from the formula brand that's #1 RECOMMENDED BY PEDIATRICIANS
- Baby Formula Focus: Prematurity, Growth Support, Brain Development, Eye Development, Immune System Support
- Base Ingredient: Milk
- Dietary Needs: Naturally Flavored, Non-GMO Project Verified
- Features: Non-GMO
- Form: Liquid
- State of Readiness: Ready to Drink
- Package Quantity: 6
- Age Stage: Infant
- Net weight: 2 fl oz (US)
Soumettez vos commentaires
Your email address will not be published. Required fields are marked *